Literature DB >> 19254479

Induction of Th1-type immune response by chitosan nanoparticles containing plasmid DNA encoding house dust mite allergen Der p 2 for oral vaccination in mice.

Guo Ping Li1, Zhi Gang Liu, Bin Liao, Nan Shan Zhong.   

Abstract

This study was to prepare the chitosan-pDer p 2 nanoparticles and to investigate the effect of chitosan-DNA nanoparticles on immune response in mice by oral delivery of chitosan-DNA nanoparticles. The nanoparticles were synthesized by complexing chitosan with plasmid DNA. The DNA was fully complexed into chitosan-DNA nanoparticles, suggesting a 100% encapsulation efficiency. Chitosan-DNA complex renders a significant protection of the plasmid. No effect on cell viability was observed in both cell types and average cell viability over 100% was obtained. Oral gene delivery with chitosan-DNA nanoparticles can generate a higher level expression of gene in vivo. Oral chitosan-pDer p 2 nanoparticles in BALB/c mice can induce IFN-gamma in serum and prevent subsequent sensitization of Th2 cell-regulated specific IgE responses. The data indicate that the oral administration of chitosan-pDer p 2 nanoparticles results in the expression of Der p 2 in the epithelial cells of both stomach and small intestine and the induction of Th1-type immune response.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19254479      PMCID: PMC4002549          DOI: 10.1038/cmi.2009.6

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  15 in total

1.  Screening and identification of mimotopes of the major shrimp allergen tropomyosin using one-bead-one-compound peptide libraries.

Authors:  Nicki Yh Leung; Christine Yy Wai; Marco Hk Ho; Ruiwu Liu; Kit S Lam; Jin Jun Wang; Shang An Shu; Ka Hou Chu; Patrick Sc Leung
Journal:  Cell Mol Immunol       Date:  2015-09-14       Impact factor: 11.530

Review 2.  Polymeric nanoparticle drug delivery technologies for oral delivery applications.

Authors:  Eric M Pridgen; Frank Alexis; Omid C Farokhzad
Journal:  Expert Opin Drug Deliv       Date:  2015-03-26       Impact factor: 6.648

Review 3.  Murine models for mucosal tolerance in allergy.

Authors:  Ursula Smole; Irma Schabussova; Winfried F Pickl; Ursula Wiedermann
Journal:  Semin Immunol       Date:  2017-08-12       Impact factor: 11.130

Review 4.  Adjuvants for allergy immunotherapeutics.

Authors:  Carlos Gamazo; Carmen D'Amelio; Gabriel Gastaminza; Marta Ferrer; Juan M Irache
Journal:  Hum Vaccin Immunother       Date:  2017-10-03       Impact factor: 3.452

Review 5.  Strategies of mucosal immunotherapy for allergic diseases.

Authors:  Yi-Ling Ye; Ya-Hui Chuang; Bor-Luen Chiang
Journal:  Cell Mol Immunol       Date:  2011-06-13       Impact factor: 11.530

Review 6.  Chitins and chitosans as immunoadjuvants and non-allergenic drug carriers.

Authors:  Riccardo A A Muzzarelli
Journal:  Mar Drugs       Date:  2010-02-21       Impact factor: 5.118

7.  Poliglusam Nanoparticles Activate T Cell Response in Breast Cancer Cell: an In Vivo and In Vitro Study.

Authors:  Neda Soleimani; Akbar Vaseghi; Valentina Loconte
Journal:  J Fluoresc       Date:  2019-09-06       Impact factor: 2.217

8.  Ultrasonic synthetic technique to manufacture a pHEMA nanopolymeric-based vaccine against the H6N2 avian influenza virus: a preliminary investigation.

Authors:  Gérrard Eddy Jai Poinern; Xuan Thi Le; Songhua Shan; Trevor Ellis; Stan Fenwick; John Edwards; Derek Fawcett
Journal:  Int J Nanomedicine       Date:  2011-09-28

Review 9.  Demystifying particle-based oral vaccines.

Authors:  Pedro Gonzalez-Cruz; Harvinder Singh Gill
Journal:  Expert Opin Drug Deliv       Date:  2021-07-06       Impact factor: 8.129

Review 10.  Chitosans for delivery of nucleic acids.

Authors:  Michael D Buschmann; Abderrazzak Merzouki; Marc Lavertu; Marc Thibault; Myriam Jean; Vincent Darras
Journal:  Adv Drug Deliv Rev       Date:  2013-07-18       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.